|
|
Volumn , Issue , 2014, Pages 61-69
|
|
Precision cancer medicine: the future is now, only better
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
FORECASTING;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
MASS COMMUNICATION;
METABOLISM;
METASTASIS;
MOLECULAR DIAGNOSIS;
MOLECULARLY TARGETED THERAPY;
NEOPLASMS;
ONCOLOGY;
PATHOLOGY;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PHENOTYPE;
PREDICTIVE VALUE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
TRENDS;
ANTINEOPLASTIC AGENTS;
DIFFUSION OF INNOVATION;
FORECASTING;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
INDIVIDUALIZED MEDICINE;
MEDICAL ONCOLOGY;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MOLECULAR TARGETED THERAPY;
NEOPLASM METASTASIS;
NEOPLASMS;
PATIENT SELECTION;
PHENOTYPE;
PREDICTIVE VALUE OF TESTS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84907330093
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.61 Document Type: Review |
|
Times cited : (38)
|
|
References (0)
|